{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:30:17Z","timestamp":1761708617325},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T00:00:00Z","timestamp":1289433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00059-010-3403-6","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T16:31:32Z","timestamp":1289320292000},"page":"542-549","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostik und Therapie der Endokarditis"],"prefix":"10.1007","volume":"35","author":[{"given":"B.","family":"Plicht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Erbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,11]]},"reference":[{"key":"3403_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12181-010-0282-2","volume":"4","author":"Al-Nawas","year":"2010","unstructured":"Al-Nawas B, Block M, Ertl G et al (2010) Kommentierte Zusammenfassung der Leitlinien der European Society of Cardiology zur Infekti\u00f6sen Endokarditis (Neuauflage 2009). Kardiologe 4:285\u2013294","journal-title":"Kardiologe"},{"key":"3403_CR2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","volume":"48","author":"Cosgrove","year":"2009","unstructured":"Cosgrove SE, Vigliani GA, Fowler VG Jr et al (2009) Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 48:713\u2013721","journal-title":"Clin Infect Dis"},{"key":"3403_CR3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ahj.2007.07.023","volume":"154","author":"Dickerman","year":"2007","unstructured":"Dickerman SA, Abrutyn E, Barsic B et al (2007) The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 154:1086\u20131094","journal-title":"Am Heart J"},{"key":"3403_CR4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","volume":"96","author":"Durack","year":"1994","unstructured":"Durack DT, Lukes AS, Bright DK (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96:200\u2013209","journal-title":"Am J Med"},{"key":"3403_CR5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkl044","volume":"57","author":"Falagas","year":"2006","unstructured":"Falagas ME, Matthaiou DK, Bliziotis IA (2006) The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 57:639\u2013647","journal-title":"J Antimicrob Chemother"},{"key":"3403_CR6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"Fowler","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR et al (2006) Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355:653\u2013665","journal-title":"N Engl J Med"},{"key":"3403_CR7","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","volume":"293","author":"Fowler","year":"2005","unstructured":"Fowler VG Jr, Miro JM, Hoen B et al (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012\u20133021","journal-title":"JAMA"},{"key":"3403_CR8","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"Habib","year":"2009","unstructured":"Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369\u20132413","journal-title":"Eur Heart J"},{"key":"3403_CR9","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.00422-06","volume":"50","author":"Howden","year":"2006","unstructured":"Howden BP, Johnson PD, Ward PB et al (2006) Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 50:3039\u20133047","journal-title":"Antimicrob Agents Chemother"},{"key":"3403_CR10","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.amjmed.2007.07.011","volume":"120","author":"Levine","year":"2007","unstructured":"Levine DP, Lamp KC (2007) Daptomycin in the treatment of patients with infective endocarditis: experience from a registry. Am J Med 120:S28\u2013S33","journal-title":"Am J Med"},{"key":"3403_CR11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633\u2013638","journal-title":"Clin Infect Dis"},{"key":"3403_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(03)15266-X","volume":"363","author":"Moreillon","year":"2004","unstructured":"Moreillon P, Que YA (2004) Infective endocarditis. Lancet 363:139\u2013149","journal-title":"Lancet"},{"key":"3403_CR13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","volume":"169","author":"Murdoch","year":"2009","unstructured":"Murdoch DR, Corey GR, Hoen B et al (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169:463\u2013473","journal-title":"Arch Intern Med"},{"key":"3403_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12181-007-0037-x","volume":"1","author":"Naber","year":"2007","unstructured":"Naber CK, Al-Nawas B, Baumgartner H et al (2007) Prophylaxe der infekti\u00f6sen Endokarditis. Kardiologe 1:243\u2013250","journal-title":"Kardiologe"},{"key":"3403_CR15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00392-004-0183-0","volume":"93","author":"Naber","year":"2004","unstructured":"Naber CK, Bauhofer A, Block M et al (2004) S2-Leitlinie zur Diagnostik und Therapie der infekti\u00f6sen Endokarditis. Z Kardiol 93:1005\u20131021","journal-title":"Z Kardiol"},{"key":"3403_CR16","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.ijantimicag.2007.07.017","volume":"30","author":"Naber","year":"2007","unstructured":"Naber CK, Erbel R (2007) Infective endocarditis with negative blood cultures. Int J Antimicrob Agents 30(Suppl 1):S32\u2013S36","journal-title":"Int J Antimicrob Agents"},{"key":"3403_CR17","doi-asserted-by":"crossref","unstructured":"Oliver R, Roberts GJ, Hooper L, Worthington HV (2008) Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev CD003813","DOI":"10.1002\/14651858.CD003813.pub3"},{"key":"3403_CR18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","volume":"328","author":"Paul","year":"2004","unstructured":"Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328:668","journal-title":"BMJ"},{"key":"3403_CR19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bdj.4809795","volume":"185","author":"Roberts","year":"1998","unstructured":"Roberts GJ, Simmons NB, Longhurst P, Hewitt PB (1998) Bacteraemia following local anaesthetic injections in children. Br Dent J 185:295\u2013298","journal-title":"Br Dent J"},{"key":"3403_CR20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/510386","volume":"44","author":"Stryjewski","year":"2007","unstructured":"Stryjewski ME, Szczech LA, Benjamin DK Jr et al (2007) Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 44:190\u2013196","journal-title":"Clin Infect Dis"},{"key":"3403_CR21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","volume":"116","author":"Wilson","year":"2007","unstructured":"Wilson W, Taubert KA, Gewitz M et al (2007) Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116:1736\u20131754","journal-title":"Circulation"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-010-3403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-010-3403-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-010-3403-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:58:06Z","timestamp":1559782686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-010-3403-6"}},"subtitle":["Aktuelle ESC-Leitlinie"],"short-title":[],"issued":{"date-parts":[[2010,11,11]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["3403"],"URL":"https:\/\/doi.org\/10.1007\/s00059-010-3403-6","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,11]]}}}